Taro Pharmaceutical Industries Ltd (NYSE:TARO)

75.92
Delayed Data
As of 6:30pm ET
 -0.93 / -1.21%
Today’s Change
72.97
Today|||52-Week Range
109.42
-10.30%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$3.0B

Company Description

Taro Pharmaceutical Industries Ltd. is engaged in the development, manufacturing, and marketing of prescribed and over-the-counter pharmaceutical products in the U.S., Canada, and Israel. Its products include semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. The company was founded in 1950 and is headquartered in Haifa Bay, Israel.

Contact Information

Taro Pharmaceutical Industries Ltd.
14 Hakitor Street
Haifa Bay Haifa 26247
P:(724) 847-5700
Investor Relations:

Employees

Shareholders

Mutual fund holders5.96%
Other institutional5.09%
Individual stakeholders11.76%

Top Executives

There are no executives to display.